Sputum antinuclear antibody serves as a biomarker for severe asthma

Allergy. 2021 Dec;76(12):3832-3835. doi: 10.1111/all.15086. Epub 2021 Sep 24.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Antinuclear*
  • Asthma* / diagnosis
  • Biomarkers
  • Eosinophils
  • Humans
  • Sputum

Substances

  • Antibodies, Antinuclear
  • Biomarkers